Search
for
Sort by
Research 61–90 of 1000+
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Perforating folliculitis with jaundice in an Indian male: a rare case with sclerosing cholangitis
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- JAK Inhibitors in the Treatment of Lichen Planopilaris
- Janus Kinase Inhibitors for Alopecia Areata
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Effects of porcine acellular dermal matrix treatment on wound healing and scar formation: Role of Jag1 expression in epidermal stem cells
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Positive Jacquet's sign in traction alopecia
- Effectiveness of the combinational treatment of<i>Laminaria japonica</i>and<i>Cistanche tubulosa</i>extracts in hair growth
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis